Moreover, our group has recently demonstrated HDAC6 inhibition as an effective treatment against TGF-β-induced idiopathic pulmonary fibrosis, we believe taking advantage of this new property of HDAC6 will boost our strategy towards treating the disease.21 Here, HDAC6 is linked to idiopathic pulmonary fibrosis.